ioversol has been researched along with Exanthem in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gómez Gratacos, AR | 1 |
| Joyanes Romo, JB | 1 |
| Meneses Sotomayor, JV | 1 |
| Martin Iglesias, MA | 1 |
| Palacios Cañas, A | 1 |
| Gómez Torrijos, E | 1 |
| Poliak, N | 1 |
| Elias, M | 1 |
| Cianferoni, A | 1 |
| Treat, J | 1 |
2 other studies available for ioversol and Exanthem
| Article | Year |
|---|---|
Maculopapular rash due to delayed-type hypersensitivity from ioversol with positive patch tests.
Topics: Dermatitis, Allergic Contact; Exanthema; Humans; Hypersensitivity, Delayed; Patch Tests; Triiodobenz | 2022 |
Acute generalized exanthematous pustulosis: the first pediatric case caused by a contrast agent.
Topics: Acute Generalized Exanthematous Pustulosis; Cardiac Catheterization; Child, Preschool; Contrast Medi | 2010 |